Skip to main content
SpringerLink
Log in

Dapagliflozin/metformin/lercanidipine

Anti-HMGCR immune-mediated necrotising myopathy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Stella M, et al. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors. Neurological Sciences 43: 4567-4570, No. 7, Jul 2022. Available from: URL: http://doi.org/10.1007/s10072-022-06046-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dapagliflozin/metformin/lercanidipine. Reactions Weekly 1918, 178 (2022). https://doi.org/10.1007/s40278-022-20635-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-20635-7

Search

Navigation